Telix Pharmaceuticals Limited TLPPF

Set alert

Price alert · TLPPF

All alert types
8.95 USD +0.15 +1.70%

At close · Oct 30

8.80 Day range 8.80
5.91 52-week range 13.00
YTD
+15.63%
1 year
-18.64%
Open
8.80
Prev close
8.80
Mkt cap
3.04B
Vol
400
Avg vol
1.84K
EPS
0.10
P/E
89.50
More statistics
Low
8.80
High
8.80
Earnings
Aug 20, 2026

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for TLPPF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.71 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -362×
FY 2016: -5037×FY 2017: -28.0×FY 2018: -22.6×FY 2019: -12.1×FY 2020: -22.9×FY 2021: -26.9×FY 2022: -21.0×FY 2023: 619×FY 2024: 161×FY 2025: -362×
FY 2016 5y median -21.0× FY 2025
P/S 3.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 1601×FY 2019: 97.3×FY 2020: 192×FY 2021: 290×FY 2022: 13.4×FY 2023: 6.4×FY 2024: 10.2×FY 2025: 3.2×
FY 2016 5y median 10.2× FY 2025
P/B 6.3×
FY 2016: 0.0×FY 2017: 3.6×FY 2018: 5.9×FY 2019: 4.8×FY 2020: 12.7×FY 2021: 1022×FY 2022: 26.9×FY 2023: 21.6×FY 2024: 14.1×FY 2025: 6.3×
FY 2016 5y median 21.6× FY 2025
P/FCF -46.6×
FY 2016: 0.0×FY 2017: -29.6×FY 2018: -15.1×FY 2019: -14.3×FY 2020: 612×FY 2021: -36.3×FY 2022: -27.6×FY 2023: 246×FY 2024: 891×FY 2025: -46.6×
FY 2016 5y median -27.6× FY 2025
EV/EBITDA 54.4×
FY 2016: 0.0×FY 2017: -20.0×FY 2018: -10.4×FY 2019: -12.1×FY 2020: -20.8×FY 2021: -31.2×FY 2022: -22.0×FY 2023: 134×FY 2024: 78.8×FY 2025: 54.4×
FY 2016 5y median 54.4× FY 2025
EV/Sales 3.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 1478×FY 2019: 85.1×FY 2020: 178×FY 2021: 288×FY 2022: 12.8×FY 2023: 6.2×FY 2024: 10.1×FY 2025: 3.6×
FY 2016 5y median 10.1× FY 2025
FCF Yield -2.1%
FY 2016: 0.0%FY 2017: -3.4%FY 2018: -6.6%FY 2019: -7.0%FY 2020: 0.2%FY 2021: -2.8%FY 2022: -3.6%FY 2023: 0.4%FY 2024: 0.1%FY 2025: -2.1%
FY 2016 5y median -2.1% FY 2025

Profitability

Gross Margin 53.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 100.0%FY 2019: -340.7%FY 2020: 61.2%FY 2021: 66.5%FY 2022: 59.3%FY 2023: 62.6%FY 2024: 65.1%FY 2025: 53.1%
FY 2016 5y median 62.6% FY 2025
Operating Margin 2.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -14158.2%FY 2019: -1155.1%FY 2020: -851.2%FY 2021: -1001.5%FY 2022: -57.4%FY 2023: 10.5%FY 2024: 10.5%FY 2025: 2.2%
FY 2016 5y median 2.2% FY 2025
Net Margin -0.9%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -7087.1%FY 2019: -799.6%FY 2020: -861.1%FY 2021: -1059.9%FY 2022: -65.0%FY 2023: 1.0%FY 2024: 6.4%FY 2025: -0.9%
FY 2016 5y median -0.9% FY 2025
ROE -1.7%
FY 2016: 0.0%FY 2017: -12.9%FY 2018: -26.1%FY 2019: -39.8%FY 2020: -56.8%FY 2021: -3730.8%FY 2022: -130.1%FY 2023: 3.5%FY 2024: 8.8%FY 2025: -1.7%
FY 2016 5y median -1.7% FY 2025
ROIC 1.9%
FY 2016: 0.0%FY 2017: -11.7%FY 2018: -34.9%FY 2019: -39.0%FY 2020: -30.0%FY 2021: -80.8%FY 2022: -52.1%FY 2023: 21.7%FY 2024: 6.1%FY 2025: 1.9%
FY 2016 5y median 1.9% FY 2025
ROA -0.6%
FY 2016: 0.0%FY 2017: -12.5%FY 2018: -18.0%FY 2019: -27.2%FY 2020: -28.4%FY 2021: -73.3%FY 2022: -39.9%FY 2023: 1.3%FY 2024: 3.3%FY 2025: -0.6%
FY 2016 5y median -0.6% FY 2025

Growth (YoY)

Revenue 4.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 1685.9%FY 2020: 49.6%FY 2021: 45.7%FY 2022: 2007.6%FY 2023: 213.9%FY 2024: 55.8%FY 2025: 4.2%
FY 2016 FY 2025
Operating Income -78.0%
FY 2016: 74.1%FY 2017: -19321.8%FY 2018: -374.2%FY 2019: -45.7%FY 2020: -10.2%FY 2021: -71.4%FY 2022: -20.8%FY 2023: 157.2%FY 2024: 56.1%FY 2025: -78.0%
FY 2016 FY 2025
EPS (diluted) -115.3%
FY 2016: 81.3%FY 2017: -16500.0%FY 2018: -37.3%FY 2019: -75.4%FY 2020: -41.7%FY 2021: -70.6%FY 2022: -13.8%FY 2023: 104.9%FY 2024: 769.6%FY 2025: -115.3%
FY 2016 FY 2025
Free Cash Flow -723.3%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -243.7%FY 2019: -14.7%FY 2020: 106.9%FY 2021: -3803.7%FY 2022: -28.3%FY 2023: 116.8%FY 2024: -31.3%FY 2025: -723.3%
FY 2016 FY 2025

Financial Health

Current Ratio 1.4×
FY 2016: 0.0×FY 2017: 33.7×FY 2018: 4.4×FY 2019: 5.5×FY 2020: 4.7×FY 2021: 1.3×FY 2022: 2.0×FY 2023: 1.4×FY 2024: 2.8×FY 2025: 1.4×
FY 2016 5y median 1.4× FY 2025
Quick Ratio 1.3×
FY 2016: 0.0×FY 2017: 33.7×FY 2018: 4.3×FY 2019: 5.5×FY 2020: 4.7×FY 2021: 1.2×FY 2022: 2.0×FY 2023: 1.3×FY 2024: 2.7×FY 2025: 1.3×
FY 2016 5y median 1.3× FY 2025
Debt / Equity 1.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 1.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 1.0×FY 2025: 1.1×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 6.0×
FY 2016: 0.0×FY 2017: 7.4×FY 2018: 0.9×FY 2019: 1.7×FY 2020: 1.7×FY 2021: 0.3×FY 2022: 1.1×FY 2023: -4.5×FY 2024: -1.3×FY 2025: 6.0×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.5×
FY 2016: 0.0×FY 2017: -620×FY 2018: -952×FY 2019: -16.7×FY 2020: -37.8×FY 2021: -403×FY 2022: -226×FY 2023: 5.9×FY 2024: 3.8×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 30.7%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -859.2%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31